SEO URLwww.firestrike.ai/deals/clario-thermo-fisher-scientific-acquisition-2026-2

acquisitionAnnounced · Jan 20, 2026Clinical Trial Data SolutionsSource · CredibleArticle · Factual

Clario · Thermo Fisher Scientific

Thermo Fisher Scientific acquires Clario

David Najork · Founding Software Engineer

Announced Jan 20, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$8.875B

Target

Clario

Philadelphia, Pennsylvania

Acquirer

Thermo Fisher Scientific

Full Acquisition

Status

Pending

Thermo Fisher Scientific agreed to acquire Clario. Reported deal value: $8.875B. Status: Pending. Sector: Clinical Trial Data Solutions. Target headquarters context: Philadelphia, Pennsylvania, United States.

This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.

Thermo Fisher proposal to acquire Clario Holdings to be reviewed in Australia January 20, 2026, 12:38 AM GMT MLex Summary: The US-based life sciences company Thermo Fisher Scientific bid to acquire clinical - trial technology provider Clario Holdings will be reviewed by Australia competition regulator

Deal timeline

Announced

Jan 20, 2026 · mlex.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Clinical Trial Data Solutions with a reported deal value of $8.875B. Figures and status may change as sources update.

Sources: mlex.com · Primary article · FireStrike proprietary index